Treatment of Chronic Inflammatory Sinusitis with Steroids
Intranasal corticosteroids should be your first-line steroid therapy for chronic inflammatory sinusitis, used daily as maintenance treatment, with short courses of oral corticosteroids (2-3 weeks) reserved only for severe cases with nasal polyps or marked mucosal edema. 1, 2
Primary Treatment Approach: Intranasal Corticosteroids
Intranasal corticosteroids are the most effective medication class for controlling the major symptoms of chronic sinusitis including nasal congestion, rhinorrhea, and inflammation. 1, 3 These agents work by:
- Decreasing vascular permeability and reducing inflammatory cell infiltration (especially eosinophils) 4, 1
- Inhibiting release of inflammatory mediators including histamine, leukotrienes, and prostanoids 4, 1
- Improving nasal blockage with a moderate effect size (mean difference -0.40 on a 0-3 scale) 5
The evidence supporting intranasal corticosteroids is robust: they improve overall symptom scores (standardized mean difference -0.46), reduce polyp size (standardized mean difference -0.73), and prevent polyp recurrence after surgery (relative risk 0.59). 6, 5
Specific Intranasal Corticosteroid Recommendations
- Use high-potency agents such as mometasone, fluticasone, or budesonide 4, 1
- Combine with high-volume saline irrigation for enhanced effectiveness - this is the evidence-based first-line combination therapy 1, 6
- Continue for at least 3-4 weeks before assessing response; for chronic disease, long-term maintenance is typically needed 3, 7
- Instruct patients to direct spray away from the nasal septum to minimize risk of septal perforation and epistaxis 1, 2
Common pitfall: Intranasal corticosteroids may not directly penetrate the paranasal sinuses, but their anti-inflammatory effects on the nasal mucosa and ostia are sufficient to provide clinical benefit. 4, 1
When to Add Oral Corticosteroids
Oral corticosteroids should NOT be used routinely - reserve them for specific clinical situations only. 4, 2
Indications for Short-Course Oral Steroids (2-3 weeks):
- Chronic rhinosinusitis with nasal polyps - this is the strongest indication 1, 2, 6
- Failure to respond to intranasal corticosteroids plus antibiotics after 3-5 days 2
- Marked mucosal edema on examination 1, 2
- Need for rapid symptomatic improvement in severe cases 7
Oral Corticosteroid Dosing Protocol:
Use prednisone 25 mg daily for 2 weeks, then transition to intranasal corticosteroids for maintenance. 2 Alternative regimens include methylprednisolone 1 mg/kg tapered over 15-21 days. 8
Critical limitation: The evidence for oral corticosteroids shows only short-term benefit (2-4 weeks) with effects disappearing by 10-12 weeks. 1, 8 Benefits include:
- Modest improvement in symptom resolution (risk ratio 1.17 for facial pain relief at 4-7 days) 2
- Temporary reduction in polyp size for up to 3 months 1, 6
- Improved total symptom scores at 2-4 weeks 1
What NOT to Do
Do not use oral corticosteroids as monotherapy - they must always be combined with intranasal corticosteroids. 1, 2
Do not use systemic steroids for acute post-viral rhinosinusitis - the evidence shows no benefit and the condition is self-limiting. 1, 2
Avoid antihistamines for routine sinusitis treatment - they have side effects without proven efficacy in relieving sinus symptoms. 4, 3
Complete Treatment Algorithm
Start all patients with chronic inflammatory sinusitis on:
If bacterial infection is documented (symptoms ≥10 days or severe symptoms with fever/purulent discharge):
If nasal polyps are present or patient fails initial therapy:
If no improvement after 3-4 weeks of appropriate therapy:
Safety Considerations
Intranasal corticosteroids are safe for long-term use - at recommended doses they do not cause clinically significant systemic effects. 4, 3 The main adverse effect is epistaxis (risk ratio 2.74), but this typically consists of minor streaks of blood. 5
Short courses of oral corticosteroids (≤3 weeks) have low risk of significant adverse events, though patients may experience insomnia, mood changes, and gastrointestinal disturbances. 1, 8
Monitor patients on oral steroids who have diabetes - use the lower dose range (prednisone 25 mg rather than higher doses) to minimize glycemic fluctuations. 2
Periodically examine the nasal septum in patients on long-term intranasal corticosteroids to check for mucosal erosions. 1, 3